Search results for " Medical imaging"

showing 10 items of 1067 documents

Cohort Profile: the EPI-CT study: a European pooled epidemiological study to quantify the risk of radiation-induced cancer from paediatric CT

2018

International audience; •The multinational EPI-CT study was set-up in 2011 to provide direct estimates of risk of solid tumours and leukaemia among children and young adults who underwent computed tomography (CT) scanning and to consolidate the scientific basis for optimization of paediatric CT protocols and patient protection.•Under a common protocol, cohort studies were conducted in Belgium, Denmark, France, Germany, the Netherlands, Norway, Spain, Sweden and the United Kingdom, coordinated by the International Agency for Research on Cancer (IARC). •The study recruited a total of about 950,000 patients having undergone at least one CT-scan before the age of 22 years. A total of 8.7 millio…

MaleOncologymedicine.medical_specialtyNeoplasms Radiation-InducedAdolescentEpidemiology[SDV]Life Sciences [q-bio]PediatricsRisk Assessment030218 nuclear medicine & medical imagingYoung Adult03 medical and health sciencesRadiation Protection0302 clinical medicineRisk FactorsRadiation IonizingInternal medicineEpidemiologymedicineHumansYoung adultChildCohort ProfilesRetrospective Studiesbusiness.industryInfant NewbornInfantCancerRetrospective cohort studyGeneral Medicinemedicine.disease3. Good healthEuropeEpidemiologic StudiesMulticenter studyChild Preschool030220 oncology & carcinogenesisCohortFemaleRadiation-induced cancerTomography X-Ray ComputedRisk assessmentbusinessInternational Journal of Epidemiology
researchProduct

Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Fe…

2017

The aim of this study was to evaluate the acute toxicity profiles of a moderate hypofractionated regimen with volumetric modulated arc therapy (VMAT) in patients with prostate cancer (PC) who underwent radical prostatectomy.From December 2012 to February 2016, 125 patients, previously having undergone radical prostatectomy, received adjuvant (64 patients) or salvage (61 patients) radiotherapy (RT) inside an institutional protocol of moderate hypofractionation schedule using the VMAT technique (Varian RapidArc, Palo Alto, CA). Eligible patients were 85 years old, with an Eastern Cooperative Oncology Group performance status of 0 to 2, histologically proven adenocarcinoma of the prostate with…

MaleOncologymedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyUrinary incontinenceDisease-Free Survival030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancersymbols.namesake0302 clinical medicineInternal medicinemedicineHumansAdjuvantFisher's exact testAgedNeoplasm StagingAged 80 and overProstatectomySalvage TherapyProstate cancerRadiotherapyAdjuvant; Hypofractionation; Prostate cancer; Radiotherapy; Salvage; Oncology; Urologybusiness.industryProstatectomyProstatic NeoplasmsCommon Terminology Criteria for Adverse EventsMiddle AgedProstate-Specific Antigenmedicine.diseaseAcute toxicityRadiation therapyRegimenTreatment OutcomeOncology030220 oncology & carcinogenesissymbolsHypofractionationSalvageRadiation Dose HypofractionationRadiotherapy AdjuvantRadiotherapy Intensity-Modulatedmedicine.symptombusinessRadiotherapy Image-GuidedClinical Genitourinary Cancer
researchProduct

High-dose-rate brachytherapy boost for prostate cancer: Analysis of dose-volume histogram parameters for predicting late, rectal toxicity

2017

PURPOSE: To determine the significance of dose-volume histogram parameters for predicting late rectal toxicity (LRT) after single-fraction high-dose-rate brachytherapy (HDRBT) boost and external beam radiotherapy (EBRT) in prostate cancer. MATERIALS AND METHODS: Three hundred patients with intermediate- or high-risk prostate cancer were included between August 2010 and March 2015. Treatment comprised a single-fraction HDRBT boost of 15.0 Gy plus EBRT (46.0 Gy delivered in 23 fractions) or an HDRBT boost of 9.5 Gy plus EBRT (60.0 Gy delivered in 30 fractions) if the seminal vesicles were infiltrated using real-time transrectal ultrasound-based planning. LRT was evaluated every 3 months after…

MaleOrgans at RiskDose-volume histogramTime Factorsmedicine.medical_treatmentBrachytherapyBrachytherapyRectumLate rectal toxicity030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancerOrgan at risk0302 clinical medicinemedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesExternal beam radiotherapyRadiation InjuriesAgedAged 80 and overProstate cancerbusiness.industryRadiotherapy Planning Computer-AssistedBiologically equivalent doseRectumProstatic NeoplasmsCommon Terminology Criteria for Adverse EventsMiddle Agedmedicine.diseaseCombined Modality TherapyHigh-Dose Rate BrachytherapyHigh-dose-rate brachytherapy boostRadiation therapyDose-volume histogram parametermedicine.anatomical_structureOncology030220 oncology & carcinogenesisRegression AnalysisDose Fractionation RadiationNuclear medicinebusinessFollow-Up Studies
researchProduct

Focal or whole-gland salvage prostate brachytherapy with iodine seeds with or without a rectal spacer for postradiotherapy local failure: How best to…

2016

International audience; PURPOSE: Salvage prostate permanent implant (sPPI) for postradiation local failure provides high rates of biochemical control. The cumulative dose delivered to the prostate and the rectum is still unknown. METHODS AND MATERIALS: We reviewed the postimplant CT-based dosimetry of 18 selected patients who underwent sPPI with I-125 seeds for isolated biopsy-proven local failure several years after external beam radiation therapy. Ten patients had whole-prostate sPPI, and 8 patients had multiparametric MRI-based focal sPPI. In 8 patients, hyaluronic acid (HA) gel was injected into the prostate rectum space. RESULTS: The median cumulative biological effective dose after EB…

MaleOrgans at Risk[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imagingmedicine.medical_treatmentBrachytherapySalvage therapyRecommendationsAlpha/Beta030218 nuclear medicine & medical imaging[ SDV.CAN ] Life Sciences [q-bio]/Cancer[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicineIodine RadioisotopesBiologically effective doseProstate cancer0302 clinical medicineProstatePositron Emission Tomography Computed Tomography[ SDV.IB ] Life Sciences [q-bio]/BioengineeringHyaluronic Acid[ SDV.IB.IMA ] Life Sciences [q-bio]/Bioengineering/ImagingProstate cancerCumulative doseCancer RecurrencesRadiotherapy DosageMenLow dose rateMiddle AgedImplantation3. Good healthmedicine.anatomical_structureOncology030220 oncology & carcinogenesis[SDV.IB]Life Sciences [q-bio]/BioengineeringLocal failureProstate brachytherapymedicine.medical_specialtyBrachytherapyRectum[SDV.CAN]Life Sciences [q-bio]/Cancer[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineRadiation Dosage03 medical and health sciencesPermanent BrachytherapymedicineHumansProctitisRadiology Nuclear Medicine and imagingRadiation InjuriesProctitisAgedSalvage TherapySalvage brachytherapyRadiotherapybusiness.industryRadiotherapy Planning Computer-AssistedCarcinomaRectumProstatic Neoplasmsmedicine.diseaseRadiation-TherapySurgeryNeoplasm Recurrence LocalTomography X-Ray ComputedNuclear medicinebusinessGels
researchProduct

Interobserver variability in rectum contouring in high-dose-rate brachytherapy for prostate cancer: A multi-institutional prospective analysis

2017

PURPOSE: The aim of this study was to evaluate the interobserver variability (KW) of rectum contouring, and its dosimetric consequences, for high-dose-rate brachytherapy in patients with prostate cancer across multiple institutions. METHODS AND MATERIALS: Five radiation oncologists contoured rectums in 10 patients on transperineal ultrasound image sets after establishing a delineation consensus. The D-0.1cc, D-1cc, and D-2cc rectum volume parameters were determined. The mean, standard deviation, and range of each dose-volume histogram parameter were evaluated for each patient. The JOY was determined using the coefficient of variation, and the dosimetric impacts on the total dose were analyz…

MaleOrgans at Riskmedicine.medical_specialtyCoefficient of variationmedicine.medical_treatmentBrachytherapyBrachytherapyRectumRadiation DosageStandard deviationEndosonography030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicineHumansMedicineRadiology Nuclear Medicine and imagingProspective StudiesObserver VariationContouringProstate cancerbusiness.industryEquivalent doseRadiotherapy Planning Computer-AssistedRectumProstatic NeoplasmsRadiotherapy DosageOrgan Sizemedicine.diseaseHigh-Dose Rate Brachytherapymedicine.anatomical_structureOncologyContouringHigh-dose-rate brachytherapy030220 oncology & carcinogenesisRadiologyInterobserver variabilitybusinessNuclear medicineBrachytherapy
researchProduct

Acute and late toxicity and preliminary outcomes report of moderately hypofractionated helical tomotherapy for localized prostate cancer: a mono-inst…

2019

Aims: To assess toxicity and clinical outcomes of moderately hypofractionated helical tomotherapy (HT) for the curative treatment of localized prostate cancer (PC). Methods: From December 2012 to May 2018, 170 patients were treated with definitive intent for PC. Thirty-four percent were low risk, 30% intermediate risk (IR) and 36% high risk (HR). All patients received 70 Gy in 28 fractions to the prostate; 61.6 Gy were delivered to the seminal vesicles for IR; pelvic lymph nodes irradiation for a total dose of 50.4 Gy was added in the HR subgroup. Toxicity was assessed using CTCAE V4.0, and biochemical failure was defined following Phoenix criteria. Time-to-event data were analyzed using th…

MaleOrgans at Riskmedicine.medical_specialtymedicine.medical_treatmentKaplan-Meier EstimateAdenocarcinomaGastroenterologyTomotherapy030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicineRetrospective StudieProstateInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingRetrospective StudiesAgedAged 80 and overProstate cancerRadiotherapybusiness.industryIncidence (epidemiology)Prostatic NeoplasmsGeneral MedicineMiddle Agedmedicine.diseaseAcute toxicityRadiation therapymedicine.anatomical_structure030220 oncology & carcinogenesisProstatic NeoplasmToxicityQuality of LifeHypofractionationAdenocarcinomaRadiation Dose HypofractionationRadiotherapy Intensity-ModulatedbusinessHumanLa radiologia medica
researchProduct

Preliminary experience with a transcranial magnetic resonance-guided focused ultrasound surgery system integrated with a 1.5-T MRI unit in a series o…

2018

OBJECTIVETranscranial magnetic resonance–guided focused ultrasound surgery (tcMRgFUS) is one of the emerging noninvasive technologies for the treatment of neurological disorders such as essential tremor (ET), idiopathic asymmetrical tremor-dominant Parkinson’s disease (PD), and neuropathic pain. In this clinical series the authors present the preliminary results achieved with the world’s first tcMRgFUS system integrated with a 1.5-T MRI unit.METHODSThe authors describe the results of tcMRgFUS in a sample of patients with ET and with PD who underwent the procedure during the period from January 2015 to September 2017. A monolateral ventralis intermedius nucleus (VIM) thalamic ablation was pe…

MaleParkinson's diseaseMovement disordershigh-intensity focused ultrasound ablationIntraoperative Neurophysiological Monitoringmedicine.medical_treatmentinterventional030218 nuclear medicine & medical imagingMagnetic resonance guided focused ultrasound surgery0302 clinical medicineThalamusEssential tremorSettore MED/27 - NeurochirurgiaUltrasoundSettore MED/37 - NeuroradiologiaParkinson DiseaseGeneral MedicineMiddle AgedAblationMagnetic Resonance ImagingTreatment OutcomeNeuropathic painBBB = blood-brain barrier; ET = essential tremor; FRFSE = fast recalled FSE; FSE = fast spin echo; FSPGR = fast spoiled gradient echo; FTM = Fahn-Tolosa-Marin; HI-FU = high-intensity focused ultrasound; MRI; MRgFUS; MS = multiple sclerosis; PD = Parkinson’s disease; Parkinson’s disease; QUEST = Quality of Life in Essential Tremor; SWAN = susceptibility-weighted angiography; UPDRS = Unified Parkinson’s Disease Rating Scale; VIM = ventralis intermedius nucleus; brain; essential tremor; high-intensity focused ultrasound ablation; interventional; magnetic resonance–guided focused ultrasound surgery; stereotactic technique; tcMRgFUS = transcranial magnetic resonance–guided focused ultrasound surgerySettore MED/26 - NeurologiaFemaleRadiologymedicine.symptombrain; essential tremor; high-intensity focused ultrasound ablation; interventional; magnetic resonance-guided focused ultrasound surgery; mrgfus; mri; parkinson's disease; stereotactic techniqueMRIAdultmedicine.medical_specialtybrainEssential Tremormagnetic resonance–guided focused ultrasound surgery03 medical and health sciencesmedicineHumansmagnetic resonance-guided focused ultrasound surgeryUltrasonography InterventionalAgedThalamotomybusiness.industryMRgFUSmedicine.diseasestereotactic techniqueparkinson's diseaseParkinson’s diseaseSurgeryNeurology (clinical)businessSettore MED/36 - Diagnostica Per Immagini E Radioterapia030217 neurology & neurosurgeryFollow-Up StudiesNeurosurgical focus
researchProduct

Effects of manganese injected into rat nostrils: implications for in vivo functional study of olfaction using MEMRI.

2011

WOS: 000298212500007; International audience; Manganese-enhanced magnetic resonance imaging (MEMRI) is a powerful tool for visualizing neuronal pathways and mapping brain activity modulation. A potential drawback of MEMRI lies in the toxic effects of manganese (Mn), which also depend on its administration route. The aim of this study was to analyze the effects of Mn doses injected into the nostrils of rats on both olfactory perception and MRI contrast enhancement. For this purpose, doses in the range 0-8 μmol MnCl(2) were tested. Behavioral items were quantified with and without odor stimulation during the first 2 h following Mn injection. The MRI study was performed after 16 h of intermitt…

MalePathologyBrain activity and meditation[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionContrast MediaStimulationPharmacologyMESH : Behavior AnimalMEMRI Manganese030218 nuclear medicine & medical imagingMESH: Magnetic Resonance Imaging0302 clinical medicineMESH: SmellMESH: Behavior AnimalMESH: AnimalsMESH: Administration IntranasalMESH : Olfactory Bulbmedicine.diagnostic_testBehavior AnimalChemistryMESH : RatsMagnetic Resonance ImagingOlfactory BulbSmellDoseToxicityMESH: Image EnhancementMESH: Olfactory Bulbmedicine.medical_specialtyMESH: RatsMESH : MaleBiomedical EngineeringBiophysicsMESH: ManganeseOlfactionMESH : Rats Wistar03 medical and health sciencesPrimary olfactory cortexIn vivoMESH : Magnetic Resonance ImagingMESH: Contrast MediamedicineAnimalsRadiology Nuclear Medicine and imagingRats WistarAdministration IntranasalMESH : Contrast MediaBehaviorManganeseToxicityMESH : Administration IntranasalMagnetic resonance imagingMESH: Rats WistarImage EnhancementOlfactionMESH: MaleRatsOdorRatMESH : SmellMESH : Image EnhancementMESH : AnimalsMESH : Manganese[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition030217 neurology & neurosurgery
researchProduct

Imaging of Orthotopic Glioblastoma Xenografts in Mice Using a Clinical CT Scanner: Comparison with Micro-CT and Histology

2016

Purpose There is an increasing need for small animal in vivo imaging in murine orthotopic glioma models. Because dedicated small animal scanners are not available ubiquitously, the applicability of a clinical CT scanner for visualization and measurement of intracerebrally growing glioma xenografts in living mice was validated. Materials and Methods 2.5x106 U87MG cells were orthotopically implanted in NOD/SCID/ᵞc-/- mice (n = 9). Mice underwent contrast-enhanced (300 μl Iomeprol i.v.) imaging using a micro-CT (80 kV, 75 μAs, 360° rotation, 1,000 projections, scan time 33 s, resolution 40 x 40 x 53 μm) and a clinical CT scanner (4-row multislice detector; 120 kV, 150 mAs, slice thickness 0.5 …

MalePathologyCancer Treatmentlcsh:MedicineContrast MediaMice SCIDSignal-To-Noise RatioDiagnostic Radiology030218 nuclear medicine & medical imagingchemistry.chemical_compound0302 clinical medicineMice Inbred NODMedicine and Health Scienceslcsh:ScienceSmall AnimalsTomographyNeurological TumorsMice KnockoutMultidisciplinarymedicine.diagnostic_testBrain NeoplasmsRadiology and ImagingBrainGliomaMagnetic Resonance ImagingIn Vivo ImagingOncologyNeurology030220 oncology & carcinogenesisFemaleAnatomyPreclinical imagingResearch ArticleInterleukin Receptor Common gamma Subunitmedicine.medical_specialtyHistologyImaging TechniquesAnimal TypesTransplantation HeterologousIomeprolBrain tumorNeuroimagingResearch and Analysis Methods03 medical and health sciencesDiagnostic MedicineCell Line TumorGliomamedicineAnimalsHumansMultislicebusiness.industrylcsh:ROrganismsBiology and Life SciencesCancers and NeoplasmsReproducibility of ResultsMagnetic resonance imagingX-Ray Microtomographymedicine.diseaseComputed Axial TomographyIopamidolTransplantationSignal-to-noise ratio (imaging)chemistrylcsh:QGlioblastomabusinessNuclear medicineZoologyNeurosciencePLOS ONE
researchProduct

Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype

2020

[EN] Background and purpose Genetic classifications are crucial for understanding the heterogeneity of glioblastoma. Recently, perfusion MRI techniques have demonstrated associations molecular alterations. In this work, we investigated whether perfusion markers within infiltrated peripheral edema were associated with proneural, mesenchymal, classical and neural subtypes. Materials and methods ONCOhabitats open web services were used to obtain the cerebral blood volume at the infiltrated peripheral edema for MRI studies of 50 glioblastoma patients from The Cancer Imaging Archive: TCGA-GBM. ANOVA and Kruskal-Wallis tests were carried out in order to assess the association between vascular fea…

MalePathologyMolecular compositionPhysiologyPeripheral edemaBrain Edema030218 nuclear medicine & medical imagingDiagnostic Radiology0302 clinical medicineVascularityMedicine and Health SciencesMedicine03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edadesEdemaCerebral Blood VolumeNeurological TumorsProneural GlioblastomaAged 80 and overMultidisciplinaryBlood VolumeBrain NeoplasmsRadiology and ImagingQRMiddle AgedPrognosisMagnetic Resonance Imaging3. Good healthBody FluidsBloodOncologyNeurology030220 oncology & carcinogenesisMedicineFemaleAnalysis of variancemedicine.symptomAnatomyPerfusionResearch ArticleAdultmedicine.medical_specialtyAdolescentImaging TechniquesBlastomaScienceResearch and Analysis Methods03 medical and health sciencesYoung AdultText miningSigns and SymptomsMalignant TumorsDiagnostic MedicineGeneticsHumansAgedRetrospective StudiesMri techniquesCancer och onkologibusiness.industryProportional hazards modelMesenchymal stem cellCancers and NeoplasmsBiology and Life Sciencesmedicine.diseaseSurvival AnalysisCancer and OncologyFISICA APLICADAClinical MedicinebusinessGlioblastoma030217 neurology & neurosurgeryGlioblastoma MultiformeMagnetic Resonance AngiographyGlioblastomaPLoS ONE
researchProduct